| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 32 |
| 1 | IBRUTINIB | 23 |
| 2 | VENETOCLAX | 16 |
| 3 | CYCLOPHOSPHAMIDE | 15 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 15 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 15 |
| 6 | OBINUTUZUMAB | 13 |
| 7 | DOXORUBICIN | 12 |
| 8 | PREDNISOLONE | 12 |
| 9 | PREDNISOLONE ORAL | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BREXUCABTAGENE AUTOLEUCEL | 6 | 0.0028 |
| 1 | PIRTOBRUTINIB | 1 | 0.0010 |
| 2 | TERBINAFINE TABLETS 250 MG | 1 | 0.0008 |
| 3 | OBINUTUZUMAB | 13 | 0.0008 |
| 4 | ZANUBRUTINIB | 2 | 0.0004 |
| 5 | RASBURICASE | 1 | 0.0004 |
| 6 | BENDAMUSTINE HYDROCHLORIDE | 3 | 0.0004 |
| 7 | BENDAMUSTINE HCL | 5 | 0.0003 |
| 8 | IBRUTINIB | 23 | 0.0003 |
| 9 | VENETOCLAX | 16 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 36 |
| 1 | Corticosteroid [EPC] | 27 |
| 2 | Kinase Inhibitor [EPC] | 25 |
| 3 | Alkylating Drug [EPC] | 16 |
| 4 | BCL-2 Inhibitor [EPC] | 16 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 11 |
| 6 | Proteasome Inhibitor [EPC] | 6 |
| 7 | Thalidomide Analog [EPC] | 6 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 4 |
| 9 | Proton Pump Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 16 | 0.0003 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 36 | 0.0001 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Alkylating Drug [EPC] | 16 | 0.0001 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 11 | 0.0001 |
| 7 | Proteasome Inhibitor [EPC] | 6 | 0.0001 |
| 8 | Kinase Inhibitor [EPC] | 25 | 0.0000 |
| 9 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |